泰利多克健康(TDOC)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 TDOC 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement Q1 2026
Item	Category	Value	YoY
Revenue	revenue	613.85M	-2.47%
Total costs and expenses	cost	675.61M	-9.92%
Cost of revenue, exclusive of depreciation, amortization, and stock-based compensation	cost	197.53M	0.35%
Advertising and marketing	cost	151.53M	-9.90%
General and administrative	cost	102.09M	-9.47%
Amortization of intangible assets	cost	89.83M	6.55%
Technology and development	cost	67.86M	-2.99%
Sales	cost	51.28M	5.30%
Restructuring costs	cost	11.97M	175.48%
Depreciation of property and equipment	cost	2.46M	-30.95%
Acquisition, integration, and transformation costs	cost	1.06M	-51.37%

Business Breakdown
Segment	Value	YoY
Teladoc Health Integrated Care	395.44M	1.53%
BetterHelp	218.40M	-8.96%

Geography Breakdown
Segment	Value	YoY
UNITED STATES	491.50M	-6.37%
Non-US	122.34M	17.19%

Products Breakdown
Segment	Value	YoY
Access Fees Revenue	484.65M	-7.81%
Other..	129.19M	24.66%

Balance Sheet Q1 2026
Item	Category	Value
Cash and cash equivalents	assets	750.74M
Accounts receivable, after allowance for credit loss, current	assets	213.63M
Prepaid expenses and other current assets	assets	136.42M
Inventories	assets	31.56M
Total current assets	assets	1.13B
Intangible assets, net	assets	1.24B
Goodwill	assets	283.19M
Other assets	assets	106.04M
Property and equipment, net	assets	26.28M
Operating lease, right-of-use asset	assets	24.23M
Assets	assets	2.81B
Liabilities	liabilities	1.47B
Total stockholders’ equity	equity	1.34B
Accumulated deficit	equity	16.49B
Accumulated other comprehensive loss	equity	35.42M
Convertible senior notes, net	liabilities	995.81M
Total current liabilities	liabilities	404.87M
Operating lease, liability, noncurrent	liabilities	31.74M
Deferred taxes, net	liabilities	27.61M
Deferred revenue, net of current portion	liabilities	10.37M
Other liabilities	liabilities	551000
Aggregate	equity	17.87B
Accrued expenses and other current liabilities	liabilities	233.29M
Contract with customer, liability, current	liabilities	65.71M
Accrued compensation	liabilities	60.67M
Accounts payable	liabilities	45.20M
Additional paid-in capital	equity	17.87B
Common stock, $0.001 par value; 300,000,000 shares authorized; 180,431,102 shares and 178,315,400 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively	equity	180000

Operating Activities – 3M 2026
Item	Value
Amortization of intangible assets	89.83M
Accrued expenses and other current liabilities	39.11M
Stock-based compensation	14.61M
Increase (decrease) in inventories	6.32M
Increase (decrease) in contract with customer, liability	5.06M
Depreciation of property and equipment	2.46M
Amortization of right-of-use assets	1.90M
Other noncash income (expense)	1.33M
Increase (decrease) in other operating assets	336000
Provision for allowances for doubtful accounts	-79000
Other liabilities	-82000
Deferred income taxes	-1.06M
Accounts payable	-2.11M
Increase (decrease) in operating lease liability	-2.30M
Increase (decrease) in accounts receivable	-21.00M
Increase (decrease) in prepaid expense and other assets	-29.45M
Accrued compensation	-31.53M
Net income	-63.84M

Investing Activities – 3M 2026
Item	Value
Payments to acquire investments	-700000
Payments to acquire property, plant, and equipment	-1.66M
Payments for software	-34.16M

Financing Activities – 3M 2026
Item	Value
Proceeds from employee stock purchase plan	399000
Other, net	-2.85M

Cash Balance – 3M 2026
Item	Value
Cash and cash equivalents, beginning of period	781.08M
Cash and cash equivalents, end of period	750.74M